Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov;150(5):489-508.
doi: 10.1007/s00418-018-1725-2. Epub 2018 Sep 27.

Gephyrin: a key regulatory protein of inhibitory synapses and beyond

Affiliations
Review

Gephyrin: a key regulatory protein of inhibitory synapses and beyond

Femke L Groeneweg et al. Histochem Cell Biol. 2018 Nov.

Abstract

Scaffolding proteins underlying postsynaptic membrane specializations are important structural and functional components of both excitatory and inhibitory synapses. At inhibitory synapses, gephyrin was identified as anchoring protein. Gephyrin self-assembles into a complex flat submembranous lattice that slows the lateral mobility of glycine and GABAA receptors, thus allowing for their clustering at postsynaptic sites. The structure and stability of the gephyrin lattice is dynamically regulated by posttranslational modifications and interactions with binding partners. As gephyrin is the core scaffolding protein for virtually all inhibitory synapses, any changes in the structure or stability of its lattice can profoundly change the packing density of inhibitory receptors and, therefore, alter inhibitory drive. Intriguingly, gephyrin plays a completely independent role in non-neuronal cells, where it facilitates two steps in the biosynthesis of the molybdenum cofactor. In this review, we provide an overview of the role of gephyrin at inhibitory synapses and beyond. We discuss its dynamic regulation, the nanoscale architecture of its synaptic lattice, and the implications of gephyrin dysfunction for neuropathologic conditions, such as Alzheimer's disease and epilepsy.

Keywords: Alzheimer; Collybistin; Epilepsy; GABA; Gephyrin; Glycine.

PubMed Disclaimer

References

    1. Hum Mutat. 2009 Jan;30(1):61-8 - PubMed
    1. Nat Commun. 2016 Nov 07;7:13365 - PubMed
    1. FEBS Lett. 1992 Jun 1;303(2-3):178-80 - PubMed
    1. Curr Pharm Des. 2016;22(5):527-34 - PubMed
    1. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3053-8 - PubMed

LinkOut - more resources